Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:November 28, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:November 28, 2023Active, not recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:October 28, 2021Recruiting
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:October 28, 2021Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:January 3, 2024Recruiting
Condition(s):Chronic Lymphocytic Leukemia (CLL); CancerLast Updated:September 1, 2023Completed
Condition(s):Adult Acute Myeloid LeukemiaLast Updated:October 18, 2023Not yet recruiting
Condition(s):Acute Myeloid Leukemia; Non-Hodgkin’s Lymphoma; Diffuse Large B-cell LymphomaLast Updated:December 7, 2021Terminated
Condition(s):Acute Myeloid LeukemiaLast Updated:August 7, 2023Active, not recruiting
Condition(s):Blastic Plasmacytoid Dendritic Cell NeoplasmLast Updated:February 13, 2024Active, not recruiting
Condition(s):Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin LymphomaLast Updated:July 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.